Duration of anticoagulation therapy for venous thromboembolism.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2008, Pages 252-258

  Bounameaux, Henri ^a   Perrier, Arnaud ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

AGE; ARTICLE; BLEEDING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; HUMAN; LUNG EMBOLISM; MALE; MIDDLE AGED; RECURRENT DISEASE; RISK; RISK FACTOR; TIME; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

AGE FACTORS; ANTICOAGULANTS; CLINICAL TRIALS AS TOPIC; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY EMBOLISM; RECURRENCE; RISK FACTORS; TIME FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 64249096246     PISSN: 15204391     EISSN: None     Source Type: Journal    
DOI: 10.1182/asheducation-2008.1.252     Document Type: Article

References (0)